Article Information
History
- August 13, 2022.
Article Versions
- Version 1 (May 7, 2022 - 10:31).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- R Packer1,8,*,
- AT Williams1,
- W Hennah4,5,6,
- MT Eisenberg2,
- KA Fawcett1,
- W Pearson1,
- A Guyatt1,
- A Edris3,1,
- EJ Hollox2,
- BS Rao7,
- JR Bratty7,
- LV Wain1,8,
- F Dudbridge1 and
- MD Tobin1,8
- 1Department of Health Sciences, University of Leicester, Leicester, UK
- 2Department of Genetics and Genome Biology, University of Leicester, Leicester, UK
- 3Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium
- 4Orion Pharma, Espoo, Finland
- 5Neuroscience Center, HiLIFE, University of Helsinki, Helsinki, Finland
- 6Institute for Molecular Medicine FIMM, HiLIFE, University of Helsinki, Helsinki, Finland
- 7Orion Pharma, Nottingham, UK
- 8Leicester National Institute of Health and Care Research Biomedical Research Centre, Glenfield Hospital, Leicester, UK
- ↵*Corresponding author; email: richard.packer{at}leicester.ac.uk